Kineticos Life Sciences supports Biopharmaceutical and Precision Medicine firms from concept to commercialization. It launched in 2007 and offers strategy, licensing, and market access consulting support for Precision Medicine. In 2012, it added portfolio strategy, business development, and commercial support. In 2020, Kineticos launched the Disruptor Fund, offering start-ups integrated intelligent funding, biotech expertise, and thoughtful execution. Kineticos remains committed to advancing the boundaries of scientific research and improving patient care.
Visit Company Website
